Daniel Lee Flynn

Insider Reports History

Entity
Individual
Location
C/O Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham, MA
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Lee Flynn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Deciphera Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 181K $2.62M $14.47 Jun 16, 2023 By Daniel L. Flynn Revocable Trust
Deciphera Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 91K $1.32M $14.47 Jun 16, 2023 By Daniel L. Flynn Irrevocable Trust
Deciphera Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 57.2K $827K $14.47 Jun 16, 2023 Direct
Deciphera Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 49.5K $716K $14.47 Jun 16, 2023 By GRAT

Insider Reports Filed by Daniel Lee Flynn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DCPH Deciphera Pharmaceuticals, Inc. Jun 16, 2023 1 -$23.8K 4 Jun 21, 2023 Chief Scientific Officer
DCPH Deciphera Pharmaceuticals, Inc. Feb 15, 2023 3 -$20.7K 4 Feb 17, 2023 Chief Scientific Officer
DCPH Deciphera Pharmaceuticals, Inc. Jan 17, 2023 1 -$51K 4 Jan 19, 2023 Chief Scientific Officer
DCPH Deciphera Pharmaceuticals, Inc. Jun 16, 2022 1 -$19K 4 Jun 21, 2022 Chief Scientific Officer
DCPH Deciphera Pharmaceuticals, Inc. Feb 16, 2022 1 -$12.4K 4 Feb 18, 2022 Chief Scientific Officer
DCPH Deciphera Pharmaceuticals, Inc. Jan 18, 2022 2 $0 4 Jan 20, 2022 Chief Scientific Officer
DCPH Deciphera Pharmaceuticals, Inc. Dec 15, 2021 2 $0 4 Dec 17, 2021 Chief Scientific Officer